IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 29-44

  Toriani Terenzi, Caterina ^a,b   Fagiolo, Enzo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE   (Italy)

Author keywords

AIHA; Cytokine network; Immunologic tolerance loss

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; EPITOPE; ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; OKT 3;

ANIMAL CELL; ANTIBODY PRODUCTION; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE ACTIVATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INCIDENCE; LYMPHOCYTE ACTIVATION; MOLECULAR MIMICRY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; TH1 CELL; TH2 CELL;

ANIMALIA; MURINAE;

EID: 25444440572     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.044     Document Type: Conference Paper

References (56)

1. THEOPHILOPOULOS, A.N. & F.J. DIXON. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-273.
2. NISITANI, S. et al. 1997. Anti-red blood cell immunoglobulin transgenic mice: an experimental model of autoimmune hemolytic anemia. Ann. N.Y. Acad. Sci. 815: 245-252.
3. THEOPHILOPOULOS, A.N. 1995. The basis of autoimmunity: Part I. Mechanism of aberrant self-recognition. Immunol. Today 6: 90-97.
4. BARKER, R.N. & C.J. ELSON. 1994. Multiple self epitopes on the rhesus polypeptide stimulate immunologically ignorant human T cells. Eur. J. Immunol. 24: 1578-1582.
5. BARKER, R.N. et al. 1997. Identification of T cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia. Blood 90: 2701-2715.
6. COUTELIER, J.P. et al. 1994. Involvement of CD4+ cells in lymphocytic choriomeningitis virus-induced autoimmune anemia. J. Autoimm. 7: 589-99.
7. FAGIOLO, E. & L. ABENANTE. 1996. Lymphocyte activation and cytokine production in autoimmune hemolytic anemia (AIHA). Autoimmunity 24: 147-156.
8. YANNEY, F.A. et al. 1978. Cold agglutinating cross-reactivity with Mycoplasma pneumoniae. Infect. Immunol. 22: 29-33.
9. LOOMES, L.M. et al. 1984. Erythrocyte receptors for Mycoplasma pneumoniae are sialy lated oligosaccarides of type II antigens. Nature 307: 560-563.
10. HAVOUIS, S. et al. 2000. Negative regulation of autoreactive B cells in transgenic mice expressing a human pathogenic cold agglutinin. Eur. J. Immunol. 30: 2290-2299.
11. HAVOUIS, S. et al. 2002. Transgenic B lymphocytes expressing a human cold agglutinin escape tolerance following experimental infection of mice by Mycoplasma pulmonis. Eur. J. Immunol. 32: 1147-1156.
12. MORRIS, S.C. et al. 1990. Autoantibodies in chronic graft versus host results from cognate T-B interactions. J. Exp. Med. 172: 503-517.
13. COX, K.O. & A. HOWLESS. 1981. Induction and regulation of autoimmune hemolytic anemia in mice. Immnol. Rev. 55: 90-97.
14. GALLART, T. et al. 1997. Anti-SiaIb (anti-Gd) cold agglutinins bind the domain: neu-NAcα 2-3 Gal in sialyl Lewis and related carbohydrates on nucleated cells in soluble cancer-associated mucins. Blood 90: 1576-1587.
15. SHERER, Y. & Y. SHOENFELD. 1997. Thymectomy and autoimmune diseases. Sem. Clin. Immunol. 1: 5-11.
16. LO, D. et al. 1995. Regulation of CD4+ cells reactivity to self and nonself. Int. Rev. Immunol. 13: 147-160.
17. ROMAGNANI, S. 1997. The Th1 and Th2 paradigm. Immunol. Today 18: 263-266.
18. SAKAGUCHI, S. et al. 1995. Immunologic tolerance mantained by activated T cells expressing IL2 receptor chain CD25: breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
19. SUZUKI, H. et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor ‰. Science 268: 1472-1476.
20. OLIVEIRA, G.G. et al. 1994. Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies. Clin. Exp. Immunol. 96: 297-302.
21. SCHEN, C.R. et al. 1996. T-helper dominated responses to erythrocyte Band 3 in NZB mice. Immunology 89:195-199.
22. SCHEN, C.R. et al. 2002. Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anemia of the NZB mouse. J. Autoimmunity 18: 149-157.
23. SCHEN, C.R. et al. 1999. Splenic but not thymic autoreactive T cells from New Zealand black mice respond to adominant Band 3 peptide. Immunology 96: 595-599.
24. JANVIER, D. et al. 2002. Severe autoimmune hemolytic anemia caused by a warm IgA autoantibody directed against the third loop of band 3. Transfusion 42: 1547-1552.
25. SARDINA, E.E. et al. 1991. Transplantation of wheat germ agglutinin positive hematopoietic cells to cells to prevent or induce systemic lupus erythematosus. Proc. Natl. Acad. Sci. 88: 1318-1323.
26. HASHIMOTO, Y. et al. 2002. Impaired development of T lymphoid precursors from pluripotent hematopoietic stem cells in New Zealand black mice. J. Immunol. 168: 81-86.
27. THORNTON, A.M. & E.M. SHEVAC. 1998. CD4+CD25+ immunoregulatory T cells suppress policlonal T cells activation in vitro by inhibiting IL2 production. J. Exp. Med. 188: 287-296.
28. MURAKAMI, M. & T. HONIO. 1997. Transgenic mouse models for B dominant autoimmune diseases. Curr. Opin. Immunol. 9: 846-850.
29. MURAKAMI, M. et al. 1994. Oral administration of lipopolysaccarides activates B1 cells in the peritoneal cavity and lamina propria of the gut an induces autoimmune symptoms in an autoantibody transgenic mice. J. Exp. Med. 180: 111-121.
30. WATANABE-FUGUNAKA, R. et al. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 356: 314-317.
31. STRAUS, S.E. 1999. An inherited disorder of lymphocyte apoptosis the autoimmune lymphoproliferative syndrome. Ann. Int. Med. 130: 591-601.
32. VIOLLARD, J.F. et al. 1999. Th1 and Th2 cytokine production by peripheral blood mononuclear cells from patients with systemic lupus erytematosus. Clin. Exp. Immunol. 115: 189-195.
33. HORWITZ, D.A. et al. 1998. Decreased production of IL12 and other Th1 type cytokine in patients with recent onset systemic lupus erythematosus. Arthritis Rheum. 41: 838-844.
34. FAGIOLO, E. & C. TORIANI-TERENZI. 1999. Enhanced IL10 production in vitro by monocytes in autoimmune hemolytic anemia. Immunol. Invest. 28: 347-352.
35. ADORINI, L. 2000. The pathogenic role of IL12 in TH1-mediated autoimmune diseases. Immunol. Immunopharm. 20: 29-35.
36. ISHIDA, H. et al. 1994. Continous administration of anti-IL10 antibodies delay onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179: 305-310.
37. NISITANI, S. et al. 1995. Administration of IL5 or IL10 activates peritoneal B1 cells and induces autoimmune hemolytic anaemia in anti-erythrocyte autoantibody transgenic mice. Eur. J. Immunol. 25: 3047-3052.
38. SAKIYAMA, T. et al. 1999. Requirement of IL5 for induction of autoimmune hemolytic anemia in anti-red blood cell autoantibody transgenic mice. Int. Immunol. 11: 995-1000.
39. RAMACANDRA, S. et al. 1996. Requirement IL10 of B1 lymphoproliferation disease in a murine model of CCL. J. Clin. Invest. 98: 1788-1793.
40. JACOB, C.O. et al. 1987. In vivo treatement of (NZB × NZW) F1 lupus-like nephritis with monoclonal antibody to γ-interferon. J. Exp. Med. 166: 798-803.
41. BALOMENOS, D. et al. 1998. Interferon-ã is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101: 364-371.
42. FAGIOLO, E. et al. 1994. High cytokine serum levels in patients with autoimmune hemolytic anemia. Immunol. Inv. 23: 449-456.
43. FAGIOLO, E. & C. TORIANI-TERENZI. 2002. Th1 and Th2 cytokine modulation by IL10/IL12 imbalance in autoimmune hemolytic anaemia. Autoimmunity 35: 39-44.
44. HALL, A.M. et al. 2002. Interleukin-10 mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood 100: 4529-4536.
45. KOUSCKOFF, V. et al. 2000. T cell-independent rescue of B lymphocytes from peripheral immune tolerance. Science 287: 2501-2503.
46. FUSS, I.J. et al. 1997. Characteristic T helper-2 cell cytokine abnormalities in autoimmune lymphoproliferative syndrome. J. Immunol. 158: 1912-1918.
47. SEGAL, B.M. et al. 1998. An IL10/IL12 immunoregulatory circuit controls susceptibility to autoimmune diseases. J. Exp. Med. 187: 537-546.
48. LEVY Y. & J.C. BROUET. 1994. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the Bcl-2 protein. J. Clin. Invest. 93: 424-428.
49. LORENTE, L. et al. 1993. Spontaneous production of interleukin-10 by lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Net. 4: 4221-4230.
50. LIU T.F. & B.M. JONES. 1998. Impaired production of IL12 in systemic lupus erythematosus: excessive production of IL10 suppress production of IL12. Cytokine 10: 140-144.
51. HOUSSIAU, F.A. et al. 1997. IL12 inhibits in vitro immunoglobulin production by lupus PMBC. Clin. Exp. Immunol. 108: 375-380.
52. LLORENTE, L. et al. 2000. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthr. Rheum. 43: 1790-1800.
53. AL-JANADI, M. et al. 1996. Interleukin-10 secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10 dependent CD4+CD45RO+ T cell-B antibody synthesis. J. Clin. Immunol. 16: 198-207.
54. BARCELLINI, W. et al. 2000. In vitro quantification of anti-red blood cell antibody production in idiophatic autoimmune hemolytic anemia: effect of mitogen and cytokine stimulation. Br. J. Haematol. 111: 452-460.
55. TORIANI-TERENZI, C. et al. 2002. Cytokine network in autoimmune hemolytic anemia: new probable targets for therapy. Cancer Prev. Det. 26: 292-298.
56. GIBSON, A.E. et al. 2001. Novel single nucleotide polymorphism in the distal IL10 promoter affect IL10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 166: 315-322.